Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

Dienestrol diacetate

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Dienestrol diacetate
Clinical data
Trade namesFaragynol, Gynocyrol
Other namesDienestrol acetate; Lipamone
Drug classNonsteroidal estrogen;Estrogen ester
Identifiers
  • [4-[(2Z,4E)-4-(4-acetyloxyphenyl)hexa-2,4-dien-3-yl]phenyl] acetate
CAS Number
PubChemCID
DrugBank
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC22H22O4
Molar mass350.414 g·mol−1
3D model (JSmol)
  • C\C=C(c1ccc(OC(C)=O)cc1)/C(=C/C)c2ccc(OC(C)=O)cc2
  • InChI=1S/C22H22O4/c1-5-21(17-7-11-19(12-8-17)25-15(3)23)22(6-2)18-9-13-20(14-10-18)26-16(4)24/h5-14H,1-4H3/b21-5-,22-6+
  • Key:YWLLGDVBTLPARJ-LWKKFVLGSA-N

Dienestrol diacetate (brand namesFaragynol,Gynocyrol, others) is asyntheticnonsteroidal estrogen of thestilbestrol group related todiethylstilbestrol.[1] It is anester ofdienestrol.[1]

Potencies of oral estrogens[data sources 1]
CompoundDosage for specific uses (mg usually)[a]
ETD[b]EPD[b]MSD[b]MSD[c]OID[c]TSD[c]
Estradiol (non-micronized)30≥120–3001206--
Estradiol (micronized)6–1260–8014–421–2>5>8
Estradiol valerate6–1260–8014–421–2->8
Estradiol benzoate-60–140----
Estriol≥20120–150[d]28–1261–6>5-
Estriol succinate-140–150[d]28–1262–6--
Estrone sulfate1260422--
Conjugated estrogens5–1260–808.4–250.625–1.25>3.757.5
Ethinylestradiol200 μg1–2280 μg20–40 μg100 μg100 μg
Mestranol300 μg1.5–3.0300–600 μg25–30 μg>80 μg-
Quinestrol300 μg2–4500 μg25–50 μg--
Methylestradiol-2----
Diethylstilbestrol2.520–30110.5–2.0>53
DES dipropionate-15–30----
Dienestrol530–40420.5–4.0--
Dienestrol diacetate3–530–60----
Hexestrol-70–110----
Chlorotrianisene->100-->48-
Methallenestril-400----
Sources and footnotes:
  1. ^Dosages are given in milligrams unless otherwise noted.
  2. ^abcDosed every 2 to 3 weeks
  3. ^abcDosed daily
  4. ^abIn divided doses, 3x/day; irregular and atypical proliferation.
Parenteral potencies and durations of nonsteroidal estrogens
EstrogenFormMajor brand name(s)EPD (14 days)Duration
Diethylstilbestrol (DES)Oil solutionMetestrol20 mg1 mg ≈ 2–3 days; 3 mg ≈ 3 days
Diethylstilbestrol dipropionateOil solutionCyren B12.5–15 mg2.5 mg ≈ 5 days
Aqueous suspension?5 mg? mg = 21–28 days
Dimestrol (DES dimethyl ether)Oil solutionDepot-Cyren, Depot-Oestromon, Retalon Retard20–40 mg?
Fosfestrol (DES diphosphate)aAqueous solutionHonvan?<1 day
Dienestrol diacetateAqueous suspensionFarmacyrol-Kristallsuspension50 mg?
Hexestrol dipropionateOil solutionHormoestrol, Retalon Oleosum25 mg?
Hexestrol diphosphateaAqueous solutionCytostesin, Pharmestrin, Retalon Aquosum?Very short
Note: All byintramuscular injection unless otherwise noted.Footnotes:a = Byintravenous injection.Sources: See template.

See also

[edit]

References

[edit]
  1. ^abElks J (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 390.ISBN 978-1-4757-2085-3.
  2. ^Lauritzen C (September 1990). "Clinical use of oestrogens and progestogens".Maturitas.12 (3):199–214.doi:10.1016/0378-5122(90)90004-P.PMID 2215269.
  3. ^Lauritzen C (June 1977). "[Estrogen thearpy in practice. 3. Estrogen preparations and combination preparations]" [Estrogen therapy in practice. 3. Estrogen preparations and combination preparations].Fortschritte Der Medizin (in German).95 (21):1388–92.PMID 559617.
  4. ^Wolf AS, Schneider HP (12 March 2013).Östrogene in Diagnostik und Therapie. Springer-Verlag. pp. 78–.ISBN 978-3-642-75101-1.
  5. ^Göretzlehner G, Lauritzen C, Römer T, Rossmanith W (1 January 2012).Praktische Hormontherapie in der Gynäkologie. Walter de Gruyter. pp. 44–.ISBN 978-3-11-024568-4.
  6. ^Knörr K, Beller FK, Lauritzen C (17 April 2013).Lehrbuch der Gynäkologie. Springer-Verlag. pp. 212–213.ISBN 978-3-662-00942-0.
  7. ^Horský J, Presl J (1981)."Hormonal Treatment of Disorders of the Menstrual Cycle". In Horsky J, Presl J (eds.).Ovarian Function and its Disorders: Diagnosis and Therapy. Springer Science & Business Media. pp. 309–332.doi:10.1007/978-94-009-8195-9_11.ISBN 978-94-009-8195-9.
  8. ^Pschyrembel W (1968).Praktische Gynäkologie: für Studierende und Ärzte. Walter de Gruyter. pp. 598–599.ISBN 978-3-11-150424-7.
  9. ^Lauritzen CH (January 1976). "The female climacteric syndrome: significance, problems, treatment".Acta Obstetricia Et Gynecologica Scandinavica. Supplement.51:47–61.doi:10.3109/00016347509156433.PMID 779393.
  10. ^Lauritzen C (1975). "The Female Climacteric Syndrome: Significance, Problems, Treatment".Acta Obstetricia et Gynecologica Scandinavica.54 (s51):48–61.doi:10.3109/00016347509156433.ISSN 0001-6349.
  11. ^Kopera H (1991). "Hormone der Gonaden".Hormonelle Therapie für die Frau. Kliniktaschenbücher. pp. 59–124.doi:10.1007/978-3-642-95670-6_6.ISBN 978-3-540-54554-5.ISSN 0172-777X.
  12. ^Scott WW, Menon M, Walsh PC (April 1980). "Hormonal Therapy of Prostatic Cancer".Cancer.45 (Suppl 7):1929–1936.doi:10.1002/cncr.1980.45.s7.1929.PMID 29603164.
  13. ^Leinung MC, Feustel PJ, Joseph J (2018)."Hormonal Treatment of Transgender Women with Oral Estradiol".Transgender Health.3 (1):74–81.doi:10.1089/trgh.2017.0035.PMC 5944393.PMID 29756046.
  14. ^Ryden AB (1950). "Natural and synthetic oestrogenic substances; their relative effectiveness when administered orally".Acta Endocrinologica.4 (2):121–39.doi:10.1530/acta.0.0040121.PMID 15432047.
  15. ^Ryden AB (1951). "The effectiveness of natural and synthetic oestrogenic substances in women".Acta Endocrinologica.8 (2):175–91.doi:10.1530/acta.0.0080175.PMID 14902290.
  16. ^Kottmeier HL (1947). "Ueber blutungen in der menopause: Speziell der klinischen bedeutung eines endometriums mit zeichen hormonaler beeinflussung: Part I".Acta Obstetricia et Gynecologica Scandinavica.27 (s6):1–121.doi:10.3109/00016344709154486.ISSN 0001-6349.There is no doubt that the conversion of the endometrium with injections of both synthetic and native estrogenic hormone preparations succeeds, but the opinion whether native, orally administered preparations can produce a proliferation mucosa changes with different authors. PEDERSEN-BJERGAARD (1939) was able to show that 90% of the folliculin taken up in the blood of the vena portae is inactivated in the liver. Neither KAUFMANN (1933, 1935), RAUSCHER (1939, 1942) nor HERRNBERGER (1941) succeeded in bringing a castration endometrium into proliferation using large doses of orally administered preparations of estrone or estradiol. Other results are reported by NEUSTAEDTER (1939), LAUTERWEIN (1940) and FERIN (1941); they succeeded in converting an atrophic castration endometrium into an unambiguous proliferation mucosa with 120–300 oestradiol or with 380 oestrone.
  17. ^Rietbrock N, Staib AH, Loew D (11 March 2013).Klinische Pharmakologie: Arzneitherapie. Springer-Verlag. pp. 426–.ISBN 978-3-642-57636-2.
  18. ^Martinez-Manautou J, Rudel HW (1966). "Antiovulatory Activity of Several Synthetic and Natural Estrogens". In Robert Benjamin Greenblatt (ed.).Ovulation: Stimulation, Suppression, and Detection. Lippincott. pp. 243–253.
  19. ^Herr F, Revesz C, Manson AJ, Jewell JB (1970). "Biological Properties of Estrogen Sulfates".Chemical and Biological Aspects of Steroid Conjugation. pp. 368–408.doi:10.1007/978-3-642-49793-3_8.ISBN 978-3-642-49506-9.
  20. ^Duncan CJ, Kistner RW, Mansell H (October 1956)."Suppression of ovulation by trip-anisyl chloroethylene (TACE)".Obstetrics and Gynecology.8 (4):399–407.PMID 13370006.
Estrogens
ERTooltip Estrogen receptor agonists
Progonadotropins
Antiestrogens
ERTooltip Estrogen receptor antagonists
(incl.SERMsTooltip selective estrogen receptor modulators/SERDsTooltip selective estrogen receptor downregulators)
Aromatase inhibitors
Antigonadotropins
Others
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown
Stub icon

Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Dienestrol_diacetate&oldid=1252448429"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp